Overview
- 85 inspections across 79 sites are on record.
- 390 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-09.
At a glance
Inspections
85
Sites
79
Observations
390
Career since
Oct 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| The Procter & Gamble Manufacturing Company | 9 Jun 2026 | Human Drugs | View 483 → |
| PQ Pharmacy LLC | 1 Jun 2026 | Human Drugs | View 483 → |
| FujiFilm Diosynth Biotechnologies U.S.A., Inc. | 27 Mar 2026 | Human Drugs | On file |
| QOL Medical LLC | 9 Jan 2026 | Human Drugs | On file |
| Pure Source, LLC | 21 Oct 2025 | Human Drugs | View 483 → |
Sites inspected
The Procter & Gamble Manufacturing CompanyGreensboro, United States1 insp.
PQ Pharmacy LLCBrooksville, United States1 insp.
FujiFilm Diosynth Biotechnologies U.S.A., Inc.Research Triangle Park, United States1 insp.
QOL Medical LLCClearwater, United States1 insp.
Pure Source, LLCDoral, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jennifer L Huntington6 shared
Kayla V Sprague4 shared
Nakesha J Jackson4 shared
Brittny C Cargo3 shared
Demario L Walls3 shared
Zhong Li2 shared
Oluwasefunm Agbanigo2 shared
Raquel Gonzalez Rivera2 shared
Jessica M Simpson2 shared
Harshal J Desai2 shared
Full investigator report
Get the verbatim findings behind Saundrea A Munroe's 390 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site